Skip to main content
Top
Published in:

19-05-2024 | Chondrosarcoma | Review

Extra-skeletal intracranial mesenchymal chondrosarcoma: systematic-literature review

Authors: Sivaraman Kumarasamy, Kanwaljeet Garg, Ajay Garg, M. C. Sharma, Manmohanjit Singh, Poodipedi Sarat Chandra, Shashank Sharad Kale

Published in: Child's Nervous System | Issue 9/2024

Login to get access

Abstract

Background

Intracranial mesenchymal chondrosarcoma (IMC) is a rare malignant tumor in pediatric population. IMC can present as extra- or intra-axial lesion in pediatric patients, though the former is commoner causing raised intracranial pressure (ICP). Radiological diagnosis is a challenge in these cases, as is it difficult to differentiate these from other extra-axial neoplasms due to the wide differential diagnosis in pediatric population. We aim to systematically review the literature and present a rare case of extraskeletal intracranial mesenchymal chondrosarcoma treated with safe maximal resection.

Methods

A systematic review of literature was conducted in accordance with PRISMA guidelines. PubMed and Scopus databases were queried using the search terms, “primary intracranial chondrosarcoma”, “extraskeletal mesenchymal chondrosarcoma”, “mesenchymal chondrosarcoma” and “pediatric”. Presentation, surgical management and outcome of a 15-year-old male with an extraskeletal IMC are also described.

Results

The search yielded 25 articles which met the inclusion criteria. These published records consisted of 33 IMC cases with mean age at presentation of 9.81 ± 5.2 years (range 2 months to 18 years). Frontal region was the commonest locations (11, 33.3%). Most common presentation was headache (14, 42.4%). All patients underwent surgical intervention: gross total resection (20, 60.6%), subtotal resection (9, 27.3%) and no extent mentioned (4, 12.1%). No adjuvant therapy was received in 15 patients (45.5%). On latest follow-up, 11 patients (33.3%) are on remission, 5 patients (15.2%) are symptom free, 3 patients (9.1%) had recurrence, 2 patients (6.1%) had metastasis and 9 patients (27.3%) expired.

Conclusion

IMC is a rare entity in pediatric population with imaging findings which are non-characteristic leading to its diagnostic challenge. It can masquerade as other extra-axial intracranial neoplasm (meningioma or hemangiopericytoma). Combination of clinico-radiological and pathological examination can help in accurate diagnosis.  Safe Maximal resection followed by radiotherapy is the preferred treatment strategy.
Literature
This content is only visible if you are logged in and have the appropriate permissions.
Metadata
Title
Extra-skeletal intracranial mesenchymal chondrosarcoma: systematic-literature review
Authors
Sivaraman Kumarasamy
Kanwaljeet Garg
Ajay Garg
M. C. Sharma
Manmohanjit Singh
Poodipedi Sarat Chandra
Shashank Sharad Kale
Publication date
19-05-2024
Publisher
Springer Berlin Heidelberg
Published in
Child's Nervous System / Issue 9/2024
Print ISSN: 0256-7040
Electronic ISSN: 1433-0350
DOI
https://doi.org/10.1007/s00381-024-06452-2

How can your team use biomarkers to improve management of AD? (Link opens in a new window)

Our experts explore using biomarker tests and interpreting results, establishing a shared decision-making approach with patients and caregivers, and applying biomarker testing to guide treatment strategies.

This content is intended for healthcare professionals outside of the UK.

Supported by:
  • Lilly
Developed by: Springer Health+ IME
Register your interest

How can you integrate PET into your practice? (Link opens in a new window)

1.5 AMA PRA Category 1 Credit(s)™

PET imaging is playing an increasingly critical role in managing AD. Our expert-led program will empower you with practical strategies and real-world case studies to effectively integrate it into clinical practice.

This content is intended for healthcare professionals outside of the UK.

Supported by:
  • Lilly
Developed by: Springer Health+ IME
Register your interest